February 7, 2024 · Form 4 insider transaction
STAHL NEIL sold 601 shares of Regeneron Pharmaceuticals, Inc. at $949.45 per share, a transaction worth $570.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents volume-weighted average price of sales of 601 shares of Company stock on February 7, 2024 at prices ranging from $949.22 to $949.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.